DUSKEY, JASON THOMAS
 Distribuzione geografica
Continente #
NA - Nord America 3.812
AS - Asia 2.121
EU - Europa 2.011
SA - Sud America 273
AF - Africa 43
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.266
Nazione #
US - Stati Uniti d'America 3.767
IT - Italia 898
CN - Cina 686
SG - Singapore 672
GB - Regno Unito 330
HK - Hong Kong 294
BR - Brasile 225
SE - Svezia 168
VN - Vietnam 164
DE - Germania 134
RU - Federazione Russa 131
FI - Finlandia 76
FR - Francia 62
ID - Indonesia 60
KR - Corea 55
NL - Olanda 36
TR - Turchia 35
BG - Bulgaria 34
IN - India 28
CA - Canada 25
JP - Giappone 25
AR - Argentina 24
MY - Malesia 24
ES - Italia 18
PL - Polonia 18
ZA - Sudafrica 18
LT - Lituania 17
UA - Ucraina 17
BD - Bangladesh 14
IE - Irlanda 14
MX - Messico 12
AT - Austria 11
BE - Belgio 11
IQ - Iraq 10
RO - Romania 10
PK - Pakistan 9
EC - Ecuador 8
CH - Svizzera 7
IL - Israele 7
MA - Marocco 7
AE - Emirati Arabi Uniti 5
UZ - Uzbekistan 5
EG - Egitto 4
GR - Grecia 4
TN - Tunisia 4
TW - Taiwan 4
VE - Venezuela 4
CL - Cile 3
CO - Colombia 3
IR - Iran 3
SA - Arabia Saudita 3
AM - Armenia 2
AN - Antille olandesi 2
AU - Australia 2
AZ - Azerbaigian 2
BY - Bielorussia 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
EE - Estonia 2
EU - Europa 2
KE - Kenya 2
LA - Repubblica Popolare Democratica del Laos 2
LY - Libia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
OM - Oman 2
PT - Portogallo 2
PY - Paraguay 2
UY - Uruguay 2
AL - Albania 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
GE - Georgia 1
GT - Guatemala 1
HR - Croazia 1
IS - Islanda 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
MD - Moldavia 1
MK - Macedonia 1
PA - Panama 1
PH - Filippine 1
SN - Senegal 1
SO - Somalia 1
SR - Suriname 1
TZ - Tanzania 1
YE - Yemen 1
Totale 8.266
Città #
Santa Clara 584
Singapore 419
Ashburn 366
Fairfield 365
Hong Kong 288
Chandler 286
Hefei 275
Woodbridge 166
Seattle 149
Cambridge 142
Modena 140
Houston 138
Southend 132
London 131
Wilmington 128
Nyköping 125
New York 102
Los Angeles 101
Beijing 95
Bologna 85
Dallas 84
Chicago 73
Munich 58
Seoul 53
Helsinki 52
Jakarta 50
Ho Chi Minh City 47
Shanghai 47
Hanoi 43
Reggio Emilia 41
San Diego 41
Ann Arbor 38
Moscow 34
Milan 33
Princeton 33
Sofia 33
Falls Church 31
Rome 30
Council Bluffs 25
The Dalles 25
São Paulo 22
Lauterbourg 21
Buffalo 19
Dearborn 18
Parma 18
Salt Lake City 18
Frankfurt am Main 17
Jacksonville 16
Turku 16
Kent 15
Warsaw 15
Castrezzato 14
Elk Grove Village 14
Nuremberg 14
Tokyo 14
Brooklyn 13
Des Moines 13
Johannesburg 13
Tampa 13
Atlanta 12
Dong Ket 12
Redondo Beach 12
Ankara 11
Dublin 11
Florence 11
Guangzhou 11
Phoenix 11
Redwood City 11
Stockholm 11
Brussels 10
Denver 10
Düsseldorf 10
Eugene 10
Izmir 10
Orem 10
Portsmouth 10
Shenzhen 10
Wuhan 10
Amsterdam 9
Da Nang 9
Montreal 9
Haiphong 8
Naples 8
Turin 8
Vienna 8
Boardman 7
Catania 7
Hounslow 7
Istanbul 7
Lappeenranta 7
Ninh Bình 7
Padova 7
Rio de Janeiro 7
Belo Horizonte 6
Brasília 6
Columbus 6
Como 6
Kilburn 6
Mountain View 6
Nanjing 6
Totale 5.751
Nome #
Current Strategies for the Delivery of Therapeutic Proteins and Enzymes to Treat Brain Disorders 322
PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept Study 267
Glioblastoma: State of the Art of Treatments and Applications of Polymeric and Lipidic Nanomedicines 265
Targeting Brain Disease in MPSII: Preclinical Evaluation of IDS-Loaded PLGA Nanoparticles 259
Hybrid nanoparticles as a new technological approach to enhance the delivery of cholesterol into the brain 246
Novel peptide-conjugated nanomedicines for brain targeting: In vivo evidence 236
Nanomedicine in Alzheimer's disease: Amyloid beta targeting strategy 235
Nanomedicine against Aβ aggregation by β–sheet breaker peptide delivery: In vitro evidence 222
Investigating Novel Syntheses of a Series of Unique Hybrid PLGA-Chitosan Polymers for Potential Therapeutic Delivery Applications 218
Drug delivery across the blood–brain barrier: recent advances in the use of nanocarriers 217
Applications of the ROS-Responsive Thioketal Linker for the Production of Smart Nanomedicines 210
Optimization of an Injectable Hydrogel Depot System for the Controlled Release of Retinal-Targeted Hybrid Nanoparticles 210
ROS-responsive “smart” polymeric conjugate: Synthesis, characterization and proof-of-concept study 204
"Combo" Multi-Target Pharmacological Therapy and New Formulations to Reduce Inflammation and Improve Endogenous Remyelination in Traumatic Spinal Cord Injury 203
Microfluidic technology for the production of hybrid nanomedicines 196
Synthesis, Characterization, and In Vitro Studies of an Reactive Oxygen Species (ROS)-Responsive Methoxy Polyethylene Glycol-Thioketal-Melphalan Prodrug for Glioblastoma Treatment 188
Insights into kinetics, release, and behavioral effects of brain-targeted hybrid nanoparticles for cholesterol delivery in Huntington's disease 182
Nanoparticle ligand presentation for targeting solid tumors 171
Nerve Growth Factor Biodelivery: A Limiting Step in Moving Toward Extensive Clinical Application? 169
Polymer-lipid hybrid nanomedicines to deliver siRNA in and against glioblastoma cells 168
Tween® preserves enzyme activity and stability in PLGA nanoparticles 164
Challenges of enzyme therapy: Why two players are better than one 163
Nanoparticles as carriers for drug delivery of macromolecules across the blood-brain barrier 157
Melatonin loaded hybrid nanomedicine: DoE approach, optimization and in vitro study on diabetic retinopathy model 155
Chronic cholesterol administration to the brain supports complete and long-lasting cognitive and motor amelioration in Huntington's disease 153
Recent Advances on Surface-Modified GBM Targeted Nanoparticles: Targeting Strategies and Surface Characterization 153
Development and biocompatibility assessments of poly(3-hydroxybutyrate-co-ε-caprolactone) microparticles for diclofenac sodium delivery 151
Enzyme Stability in Nanoparticle Preparations Part 1: Bovine Serum Albumin Improves Enzyme Function 149
Analysis of Molecular Parameters Determining the Antimalarial Activity of Polymer-Based Nanomimics 149
Metabolically stabilized long-circulating PEGylated polyacridine peptide polyplexes mediate hydrodynamically stimulated gene expression in liver 149
Engineered non-toxic cationic nanocarriers with photo-triggered slow-release properties 148
Corrigendum to “Quantitative comparison of the protein corona of nanoparticles with different matrices” [Int J Pharm X 2022 Oct 21;4: 100136] (International Journal of Pharmaceutics: X (2022) 4, (S2590156722000251), (10.1016/j.ijpx.2022.100136)) 143
Strategies for Improved pDNA Loading and Protection Using Cationic and Neutral LNPs with Industrial Scalability Potential Using Microfluidic Technology 138
Tunneling Nanotubes: A New Target for Nanomedicine? 136
Glioblastoma Multiforme Selective Nanomedicines for Improved Anti-Cancer Treatments 134
Nanowired Delivery of Curcumin Attenuates Methamphetamine Neurotoxicity and Elevates Levels of Dopamine and Brain-Derived Neurotrophic Factor 132
Advantages and challenges of polymer-lipid hybrid nanoparticles for the delivery of biotech drugs 131
Chaperonin–Dendrimer Conjugates for siRNA Delivery 130
Nanomedicine-based technologies and novel biomarkers for the diagnosis and treatment of Alzheimer’s disease: from current to future challenges 127
An overview of current drug delivery strategies for glioblastoma treatment and barriers to progress 124
New concepts to fight oxidative stress: Nanosized three-dimensional supramolecular antioxidant assemblies 121
PH-responsive PDMS-b-PDMAEMA micelles for intracellular anticancer drug delivery 116
Nanomedicines for brain diseases: Where we are and where we are going 113
The uptake mechanism of PEGylated DNA polyplexes by the liver influences gene expression 111
Miniaturization of gene transfection assays in 384- and 1536-well microplates 110
Chapter 8 - Hybrid polymeric scaffolds for brain applications: locoregional glioblastoma therapy 110
PH-Triggered Reversible Multiple Protein-Polymer Conjugation Based on Molecular Recognition 107
Structure-Activity Relationship of PEGylated Polylysine Peptides as Scavenger Receptor Inhibitors for Non-Viral Gene Delivery 107
Quantitative comparison of the protein corona of nanoparticles with different matrices 102
Stimuli-Responsive Codelivery of Oligonucleotides and Drugs by Self-Assembled Peptide Nanoparticles 98
Totale 8.369
Categoria #
all - tutte 41.594
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.594


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021561 0 0 0 0 0 102 95 80 62 93 77 52
2021/2022751 55 61 39 39 58 54 36 53 102 69 97 88
2022/2023797 94 80 56 77 79 108 24 85 98 19 41 36
2023/2024699 31 60 46 57 123 93 42 81 18 34 22 92
2024/20252.530 87 43 63 161 448 326 208 164 286 114 263 367
2025/20262.104 328 195 370 473 522 216 0 0 0 0 0 0
Totale 8.369